Babara Smith 0,0
-
Вебсайт
https://www.protheragen.us/
In addition to developing rare disease models, Protheragen also provides comprehensive orphan disease research services including drug safety evaluation, drug repurposing, artificial intelligence services, and therapeutic development solutions. As a CRO company long engaged in rare disease research, Protheragen has built a robust network of partnerships with academic institutions, pharmaceutical companies, and biotechnology firms to support this effort and improve research outcomes.
